STREAMING NOW: Watch Now

Experimental treatment uses modified stem cells to fight cancer

A clinical trial run by UCLA is testing a potentially pioneering form of immunotherapy that could turn a patient's ow...

Posted: Jul 20, 2018 5:18 PM
Updated: Jul 20, 2018 5:18 PM

A clinical trial run by UCLA is testing a potentially pioneering form of immunotherapy that could turn a patient's own body into a powerful weapon against cancer.

Researchers at the university's Jonsson Comprehensive Cancer Center are reinforcing the immune system's foundation by genetically modifying bone marrow stem cells, the cellular factories that power immune responses. By arming those cells with receptors that recognize cancer, researchers hope a patient's body will cure itself from the inside out.

Dr. Antoni Ribas, who is leading the trial, started working on cancer immunotherapy -- treatments that alter a patient's immune response to fend off cancer -- more than 20 years ago. He played a key role in the clinical development of Keytruda, Merck's popular immunotherapy drug used to treat several types of cancer including some types of melanoma (a type of skin cancer), Hodgkin's disease, some head and neck cancers, some non-small cell lung cancers, and some colorectal cancers. Now he's turning his attention to another therapy he finds especially exciting.

The immune system defends the body against sickness. T-cells play an integral role. They're a type of white blood cell that seeks out and destroys diseased cells. The trouble is, T-cells don't recognize cancerous cells as an adversary, leaving the body vulnerable.

Researchers already know how to get around that by extracting T-cells and adding the genetic code for receptors that detect cancer. The problem? Eventually those super-powered T-cells stop working. "We realized the immune system cells that we give back have a limited life span," Ribas said.

That's where the UCLA trial comes in.

Bone marrow stem cells are the factories that produce new T-cells. But rather than simply genetically modifying T-cells, Ribas is modifying the bone marrow stem cells that make them. In other words, he's modifying the car factory, not just the car.

The result, in theory, is a lifetime supply of cancer-fighting T-cells and, hopefully, a more cancer-resistant immune system. Testing that theory will require years of clinical trials. Daniel Apodaca, 25-year-old UCLA student who has epithelioid sarcoma, a rare, soft tissue cancer that grows slowly, became the trial's first patient in April.

"I didn't have any options before," Apodaca told CNNMoney. "So just having an option in general, I feel really lucky."

Ribas said doctors extracted some of Apodaca's bone marrow stem cells along with a batch of T-cells and modified them in the lab. Chemotherapy helped eradicate his existing immune system cells, making room for the new and improved ones. The immune system reboot kept Apodaca in a sterile hospital environment for three weeks. When he left on April 24th with his reprogrammed immune system, doctors called it his second birthday. But it will be years before they can definitively say the treatment worked.

Beyond the uncertainty inherent in any experimental treatment, immunotherapies come with risks and side effects, such as colitis, or colon inflammation, infection, or even a severe or fatal allergic reaction, although that's rare. And cell therapy carries the possibility that the upgraded immune system could attack healthy tissues, said Fred Ramsdell, Vice President of Research at the Parker Institute for Cancer Immunotherapy.

"As we try to amp up the immune system, we do run the risk of having the immune system recognize some of our normal tissues," and attack them, he said.

If that happens, "we'll pull the safety mechanism," Ribas said. "We [insert] a gene that allows us to kill them if they become bad."

Despite the risk, the therapy could advance the field of immunotherapy, Ramsdell said. "We need to find ways to sustain the effect of adapted cell therapies," he said. "This trial is pushing the envelope."

Achieving that progress took more than a decade of research and millions of dollars, Ribas said. The California Institute for Regenerative Medicine, a taxpayer-funded research organization, financed the trial with a $20 million grant.

Ribas estimates the therapy could cost hundreds of thousands of dollars per patient. And even if it works, big questions remain about its wider application. The key to an effective targeted immunotherapy is detecting the unique signature of a patient's specific cancer and matching it with a receptor that doctors can add to a T-cell. That's how the modified T-cell knows to attack the cancerous cells, not healthy cells. But the process of matching cancer signatures and receptors has proven difficult, and the list of matches remains relatively short.

"Our first attempt is targeting in particular two cancers, sarcomas and melanomas, because they have a protein called NY-ESO-1 that can be efficiently targeted with a receptor that we have," Ribas said. "Potentially, we could do more, but every time we use a new receptor we would have to go back to the beginning."

For now, Apodaca is responding well enough to visit his girlfriend who is finishing up school in Spain. And he manages to stay optimistic about the future. "Hopefully I become the golden child for this amazing scientific movement," he said. "I look to see some real progress in medicine and for oncology, potentially for all subtypes of cancer."

That movement remains a long way off. The therapy faces several more clinical trials and rigorous FDA review before it enters widespread use. That is, if it works. And that's a big if. But such is the nature of medical research. "That's where we push the limits of science," Ribas said. "If we don't do things like this, then we don't advance."

Huntsville
Clear
73° wxIcon
Hi: 86° Lo: 71°
Feels Like: 73°
Florence
Clear
74° wxIcon
Hi: 89° Lo: 72°
Feels Like: 74°
Fayetteville
Few Clouds
72° wxIcon
Hi: 85° Lo: 70°
Feels Like: 72°
Decatur
Clear
73° wxIcon
Hi: 88° Lo: 71°
Feels Like: 73°
Scottsboro
Overcast
75° wxIcon
Hi: 84° Lo: 70°
Feels Like: 75°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Confirmed Cases: 44375

Reported Deaths: 984
CountyConfirmedDeaths
Jefferson5221152
Montgomery4127103
Mobile4080134
Tuscaloosa228842
Marshall171110
Madison14307
Lee138437
Shelby128423
Morgan11025
Walker93924
Elmore92514
Franklin89514
Dallas8809
Baldwin8649
Etowah73913
DeKalb7195
Butler63328
Chambers62927
Autauga60712
Tallapoosa59169
Russell5520
Unassigned50323
Houston4964
Limestone4950
Lauderdale4906
Lowndes47221
Cullman4524
Pike4295
Colbert3956
St. Clair3822
Coffee3772
Bullock36910
Covington3587
Calhoun3545
Escambia3506
Barbour3492
Hale31121
Talladega3097
Marengo30211
Wilcox2918
Dale2880
Sumter28512
Clarke2746
Jackson2732
Winston2583
Chilton2462
Blount2351
Monroe2352
Pickens2356
Marion22413
Conecuh2097
Randolph2069
Choctaw19512
Macon1949
Bibb1901
Greene1868
Perry1771
Henry1343
Crenshaw1253
Washington1097
Lawrence1080
Cherokee977
Geneva800
Lamar771
Fayette701
Clay652
Coosa581
Cleburne361
Out of AL00

Tennessee Coronavirus Cases

Confirmed Cases: 51316

Reported Deaths: 645
CountyConfirmedDeaths
Shelby11793200
Davidson11089122
Rutherford298735
Hamilton278135
Sumner161052
Trousdale14985
Williamson131315
Out of TN11857
Knox11717
Wilson94117
Putnam8837
Robertson83411
Sevier8043
Bradley7073
Lake6920
Tipton6455
Unassigned6351
Bledsoe6201
Bedford5705
Montgomery5547
Macon4654
Maury3543
Hardeman3434
Hamblen3404
Fayette3172
Madison2992
Loudon2871
Rhea2860
Dyer2511
McMinn23718
Cheatham2301
Blount2273
Dickson2090
Cumberland1814
Washington1650
Lawrence1636
Lauderdale1453
Anderson1422
Monroe1406
Jefferson1360
Gibson1291
Smith1201
Coffee1190
Sullivan1172
Obion1122
Hardin1087
Greene1032
Cocke940
Haywood922
Marshall911
Franklin873
Wayne860
Hickman800
Warren760
Marion734
McNairy730
White703
DeKalb670
Lincoln640
Weakley641
Grundy621
Overton621
Roane620
Giles601
Carter591
Hawkins572
Unicoi550
Campbell481
Carroll471
Henderson460
Claiborne450
Polk450
Henry440
Johnson440
Grainger420
Sequatchie420
Crockett383
Cannon370
Chester340
Perry340
Meigs320
Humphreys281
Jackson270
Morgan271
Stewart230
Decatur220
Fentress220
Union180
Clay170
Scott170
Houston150
Benton131
Moore120
Van Buren80
Hancock60
Lewis60
Pickett60

 

 

Community Events